🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this observer blinded study is to provide information on vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-20
Trial ID
NCT00578175
Treatments Being Tested
This phase 3b study will compare the immunogenicity and reactogenicity of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-04-01
Trial ID
NCT00871000
Treatments Being Tested
This study is undertaken to generate clinical data on GSK Biologicals' comb...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-03
Trial ID
NCT00892775
Healthy children who received two doses of GlaxoSmithKline (GSK) Biological...
Status
Unknown
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT02712203
Treatments Being Tested
An observer-blind study to evaluate GlaxoSmithKline Biologicals' live atten...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-09-01
Trial ID
NCT00226499
Treatments Being Tested
The purpose of this study is to assess non-inferiority of two different vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11-09
Trial ID
NCT00969436
Treatments Being Tested
The purpose of this study is to demonstrate, in 12-23 month old children, t...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06-05
Trial ID
NCT00474266
Treatments Being Tested
This study will collect data on the safety of the MMRV vaccine (Priorix-Tet...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01738841
Treatments Being Tested
This Phase 3b study is being conducted for the purpose of registration of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-10-01
Trial ID
NCT00751348
Treatments Being Tested
Bexsero™ is a four component serogroup B meningococcal vaccine (4CMenB) lic...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT02712177
Treatments Being Tested